Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer
Open Access
- 30 May 2022
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 1712-1725
Abstract
This study aimed to explore the anti-tumor effect of icaritin loading poly (lactic-co-glycolic acid) nanoparticles (refer to PLGA@Icaritin NPs) on gastric cancer (GC) cells. Transmission Electron Microscope (TEM), size distribution, zeta potential, drug-loading capability, and other physicochemical characteristics of PLGA@Icaritin NPs were carried out. Furthermore, flow cytometry, confocal laser scanning microscope (CLSM), Cell Counting Kit-8 (CCK-8), Transwell, Elisa assay and Balb/c mice were applied to explore the cellular uptake, anti-proliferation, anti-metastasis, immune response activation effects, and related anti-tumor mechanism of PLGA@Icaritin NPs in vitro and in vivo. PLGA@Icaritin NPs showed spherical shape, with appropriate particle sizes and well drug loading and releasing capacities. Flow cytometry and CLSM results indicated that PLGA@Icaritin could efficiently enter into GC cells. CCK-8 proved that PLGA@Icaritin NPs dramatically suppressed cell growth, induced Lactic dehydrogenase (LDH) leakage, arrested more GC cells at G2 phase, and inhibited the invasion and metastasis of GC cells, compared to free icaritin. In addition, PLGA@Icaritin could help generate dozens of reactive oxygen species (ROS) within GC cells, following by significant mitochondrial membrane potentials (MMPs) loss and excessive production of oxidative-mitochondrial DNA (Ox-mitoDNA). Since that, Ox-mitoDNA further activated the releasing of damage associated molecular pattern molecules (DAMPs), and finally led to immunogenic cell death (ICD). Our in vivo data also elaborated that PLGA@Icaritin exerted a powerful inhibitory effect (∼80%), compared to free icaritin (∼60%). Most importantly, our results demonstrated that PLGA@Icaritin could activate the anti-tumor immunity via recruitment of infiltrating CD4+ cells, CD8+ T cells and increased secretion of cytokine immune factors, including interferon-γ (IFN-γ) tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1).++ Our findings validate that the successful design of PLGA@Icaritin, which can effectively active ICD and facilitate tumor recruitment in GC through inducing mitoDNA oxidative damage.Keywords
Funding Information
- The Science and Technology Program of Guangzhou (201902020001)
- The key medical discipline of Guangzhou (2021-2023)
- Guangzhou Science and Technology Project (2060206)
- General project of Guangdong Medical Science and Technology Research Fund (A2021430)
- General project of Guangdong Medical Science and Technology Research Fund (2021A031005)
- The Science and Technology Program of Guangzhou (202102020088)
This publication has 55 references indexed in Scilit:
- Icaritin, a novel plant-derived osteoinductive agent, enhances the osteogenic differentiation of human bone marrow- and human adipose tissue-derived mesenchymal stem cellsInternational Journal of Molecular Medicine, 2017
- Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cellsBiomedicine & Pharmacotherapy, 2017
- Renoprotective Effects of Total Glucosides from Paeony against Nephrotoxicity Induced by Total Alkaloids from Semen StrychniEvidence-Based Complementary and Alternative Medicine, 2017
- Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancerNature Reviews Clinical Oncology, 2016
- Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigationsJournal of Nanobiotechnology, 2016
- Synergy in traditional Chinese medicineThe Lancet Oncology, 2016
- Peptide/protein vaccine delivery system based on PLGA particlesHuman Vaccines & Immunotherapeutics, 2015
- Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphomaJournal of Experimental & Clinical Cancer Research, 2015
- A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell lineArtificial Cells, Nanomedicine, and Biotechnology, 2014
- Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology, 2013